🔎 Trials Near Me

Akèy › Neoplazmi myeloproliferatif › Washington

Etid klinik pou Neoplazmi myeloproliferatif nan Washington, DC

5 etid pou Neoplazmi myeloproliferatif ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Ap rekriteFaz 2
  • Walter Reed National Military Medical Center, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT05564390

Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

Ap rekriteFaz 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 12 a 120 · Tout sèks · Mizajou Oct 5, 2026 · NCT06303193

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Ap rekriteFaz 2
  • Walter Reed National Military Medical Center, Bethesda · 7 mi lwen
Laj 18 a 59 · Tout sèks · Mizajou Sep 22, 2026 · NCT05554406

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • MedStar Georgetown University Hospital, Washington D.C.
  • Children's National Medical Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mi lwen
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Silver Spring · 7 mi lwen
  • Massive Bio SYNERGY-AI site, Bethesda · 7 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Neoplazmi myeloproliferatif nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.